Opportunity ID: 334223

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-22-009
Funding Opportunity Title: Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 17, 2021
Last Updated Date: Jun 17, 2021
Original Closing Date for Applications: Nov 17, 2021
Current Closing Date for Applications: Nov 17, 2021
Archive Date: Dec 23, 2021
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Special district governments
Independent school districts
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
Small businesses
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites grant applications to study mechanisms underlying the neuropathophysiology of HIV-associated neurological disorders (HAND) using induced microglia and cerebral organoids generated from human derived induced pluripotent stem cell (iPSC) lines. Specific emphasis is on the comorbidity of HIV and neural stimulants, including amphetamine, methamphetamine, cocaine, and nicotine, studied at the single cell and neural circuits levels.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-009.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00267805 Oct 17, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269825 Oct 28, 2021 Nov 17, 2021 View

Package 1

Mandatory forms

334223 RR_SF424_2_0-2.0.pdf

334223 PHS398_CoverPageSupplement_5_0-5.0.pdf

334223 RR_OtherProjectInfo_1_4-1.4.pdf

334223 PerformanceSite_2_0-2.0.pdf

334223 RR_KeyPersonExpanded_2_0-2.0.pdf

334223 PHS398_ResearchPlan_4_0-4.0.pdf

334223 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

334223 RR_Budget_1_4-1.4.pdf

334223 RR_SubawardBudget30_1_4-1.4.pdf

334223 PHS398_ModularBudget_1_2-1.2.pdf

334223 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

334223 RR_SF424_5_0-5.0.pdf

334223 PHS398_CoverPageSupplement_5_0-5.0.pdf

334223 RR_OtherProjectInfo_1_4-1.4.pdf

334223 PerformanceSite_4_0-4.0.pdf

334223 RR_KeyPersonExpanded_4_0-4.0.pdf

334223 PHS398_ResearchPlan_4_0-4.0.pdf

334223 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

334223 RR_Budget_3_0-3.0.pdf

334223 RR_SubawardBudget30_3_0-3.0.pdf

334223 PHS398_ModularBudget_1_2-1.2.pdf

334223 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T12:04:06-05:00

Share This Post, Choose Your Platform!

About the Author: